Culturally-Informed Counseling in Latinas at High Risk for Hereditary Breast or Ovarian Cancer

Sponsor
City of Hope Medical Center (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT01230346
Collaborator
National Cancer Institute (NCI) (NIH)
475
3
3
147.9
158.3
1.1

Study Details

Study Description

Brief Summary

This pilot clinical trial studies a culturally-informed counseling intervention in Latinas at high risk for hereditary breast or ovarian cancer. A culturally-informed counseling intervention may be an effective method to help people learn more about their cancer risk.

Condition or Disease Intervention/Treatment Phase
  • Other: questionnaire administration
  • Other: survey administration
  • Other: counseling intervention
  • Other: educational intervention
N/A

Detailed Description

PRIMARY OBJECTIVES:
  1. To conduct a randomized trial of a culturally-informed pre-genetic cancer risk assessment (GCRA) telephone intervention.

  2. To evaluate the effect of the pre-GCRA intervention versus a time and attention control versus standard scheduling procedure alone (usual care) on levels of anxiety, perceived personal control and cancer genetics knowledge.

  3. To explore patients' experiences with the pre-GCRA intervention through post-intervention telephone interviews.

SECONDARY OBJECTIVES:
  1. To explore patients' perceived barriers to GCRA through no-show telephone interviews.
OUTLINE:

Patients are randomized to 1 of 3 treatment arms.

ARM I: Patients receive a culturally-informed adapted motivational interviewing telephone call.

ARM II: Patients participate in a controlled condition comprising a health habits intervention group.

ARM III: Patients receive usual care comprising a standard scheduling phone call and proceed with normal GCRA process. All patients are mailed standard new patient packets containing questionnaires on demographics and personal health history, and a family history form. All patients then undergo genetic cancer risk assessment.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
475 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Intervention to Promote Uptake of Cancer Risk Counseling for Underserved Latinas
Actual Study Start Date :
Sep 3, 2010
Actual Primary Completion Date :
Nov 10, 2016
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Arm I

Patients receive a culturally-informed adapted motivational interviewing telephone call.

Other: questionnaire administration
Ancillary studies

Other: survey administration
Ancillary studies

Other: counseling intervention
Telephone intervention
Other Names:
  • counseling and communications studies
  • Other: educational intervention
    Telephone intervention
    Other Names:
  • intervention, educational
  • Experimental: Arm II

    Patients participate in a controlled condition comprising a health habits intervention group.

    Other: questionnaire administration
    Ancillary studies

    Other: survey administration
    Ancillary studies

    Other: counseling intervention
    Telephone intervention
    Other Names:
  • counseling and communications studies
  • Active Comparator: Arm III

    Patients receive usual care comprising a standard scheduling phone call and proceed with normal GCRA process.

    Other: questionnaire administration
    Ancillary studies

    Other: survey administration
    Ancillary studies

    Outcome Measures

    Primary Outcome Measures

    1. Effect of pre-GCRA intervention versus a time and attention control versus standard scheduling procedure alone (usual) on levels of anxiety, perceived personal control and cancer genetic knowledge [One week after genetic cancer risk assessment (GCRA)]

      Tested using 3 x 3 repeated measures analysis of covariance (ANCOVA)s in which the within subjects variables are anxiety or perceived control, the between groups variable is group membership, and covariates include fatalism and other appropriate moderators.

    2. Experiences with the pre-GCRA intervention through post-intervention telephone interviews [One week after genetic cancer risk assessment (GCRA)]

    3. Conduct a randomized controlled trial of a culturally-informed pre-GCRA telephone intervention utilizing AMI techniques [One week after genetic cancer risk assessment (GCRA)]

      Will use a multivariate ANCOVA (MANCOVA) to test for group differences among all five preparedness scores, with step-down F ratios of each individual score, using fatalism and other moderators as covariates, as appropriate.

    Secondary Outcome Measures

    1. Perceived barriers to GCRA through no-show telephone interviews [One week after genetic cancer risk assessment (GCRA)]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Individuals who have a personal history of hereditary breast or ovarian cancer; a subset of 60 women without a personal history of hereditary or ovarian cancer will be included in an exploratory subset analysis

    • Meet NCCN criteria for consideration of genetic testing for hereditary breast cancer

    • Willing to sign consent

    • Pregnant women and women of child-bearing potential are eligible for participation in this study

    • Women who report themselves to be of Latino or Hispanic ethnic background (defined as Spanish, Mexican, Central or South American, Cuban, Puerto Rican, Dominican, or other Hispanic origin)

    • Women who are under- or uninsured and come from low-income communities

    • Ability to understand English or Spanish

    Exclusion Criteria:
    • Previous participation in GCRA

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 City of Hope Medical Center Duarte California United States 91010
    2 University of Southern California-Keck School of Medicine Los Angeles California United States 90033
    3 Olive View-UCLA Medical Center Sylmar California United States 91342

    Sponsors and Collaborators

    • City of Hope Medical Center
    • National Cancer Institute (NCI)

    Investigators

    • Principal Investigator: Jeffrey Weitzel, City of Hope Medical Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    City of Hope Medical Center
    ClinicalTrials.gov Identifier:
    NCT01230346
    Other Study ID Numbers:
    • 08237
    • NCI-2010-01998
    First Posted:
    Oct 29, 2010
    Last Update Posted:
    Mar 18, 2022
    Last Verified:
    Mar 1, 2022
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 18, 2022